Why the study?
Cardiovascular disease is a leading cause of death among cancer survivors, making cardiovascular risk mitigation an important priority.
Does the incidental finding of coronary artery calcification on cancer imaging lead to the initiation of preventive cardiovascular therapies in patients with early-stage NSCLC?
Does the incidental finding of coronary artery calcification on cancer imaging lead to the initiation of preventive cardiovascular therapies in patients with early-stage NSCLC?
Incidental coronary artery calcification is highly prevalent in early-stage NSCLC patients without known cardiovascular disease, but it rarely leads to the initiation of preventive aspirin or statin therapy, representing a missed opportunity for risk reduction.
Incidental CAC rarely prompts preventive therapy in early-stage NSCLC without ASCVD; leaves open whether systematic reporting improves risk reduction.
Cardiovascular (CV) disease is a leading cause of death among 15 million cancer survivors in the United States today [(1)][1]. Mitigating CV risk in this population should be a priority for both oncologists and cardiologists. Most patients with cancer undergo nongated chest computed tomography (
No takes yet. Share an insight, caveat, or question.
Payne et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: